Literature DB >> 20879972

Autonomic dysfunction in diabetes: a consequence of cardiovascular damage.

J D Lefrandt1, A J Smit, C J Zeebregts, R O B Gans, K H Hoogenberg.   

Abstract

In 1976, D.J. Ewing showed a clear survival disadvantage for diabetic patients that had 'diabetic autonomic neuropathy', as assessed by heart rate and blood pressure variations during a battery of bedside tests. However, these variations do not solely depend on autonomic nervous system function, but also and possibly to a more important extent on the integrity of cardiovascular autonomic reflex loops. Increased intima media thickness at the site of the baroreceptors, reduced vascular distensibility, endothelial dysfunction and impaired cardiac function contribute to the cardiovascular autonomic dysfunction. Interestingly, these abnormalities are closely associated with the presence of (micro-) albuminuria that is regarded as a reflection of endothelial dysfunction or vascular damage in diabetes mellitus. Modern techniques to assess cardiovascular autonomic, vascular and cardiac function have improved the ability to detect early abnormalities. Analysis of heart rate variability, baroreflex sensitivity, muscle sympathetic nervous activity, LNMAinfusions and advanced echocardiography have shown that it is the interplay between autonomic control and cardiac and vascular properties that determines cardiovascular autonomic function. Moreover, these modern techniques have improved power to predict survival in diabetic patients in comparison with the classical Ewing's bedside tests. In conclusion, cardiovascular damage may be more important in cardiovascular autonomic dysfunction than neural function.

Entities:  

Mesh:

Year:  2010        PMID: 20879972     DOI: 10.2174/157339910793499128

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  6 in total

1.  The association and interaction analysis of hypertension and uric acid on cardiovascular autonomic neuropathy.

Authors:  X-P Liao; H-W Zhu; F Zeng; Z-H Tang
Journal:  J Endocrinol Invest       Date:  2015-04-23       Impact factor: 4.256

2.  Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study.

Authors:  José Gomes Batista; José Maria Soares; Carla Cristina Maganhin; Ricardo Santos Simões; Geraldez Tomaz; Edmund Chada Baracat
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

3.  The Predictive Value of Serum Calcium on Heart Rate Variability and Cardiac Function in Type 2 Diabetes Patients.

Authors:  Junyi Wang; Zihui Xu; Kang Lv; Yingchun Ye; Deng Luo; Li Wan; Fen Zhou; Ailin Yu; Shuo Wang; Jingcheng Liu; Ling Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055

Review 4.  Influence of cardiac nerve status on cardiovascular regulation and cardioprotection.

Authors:  John G Kingma; Denys Simard; Jacques R Rouleau
Journal:  World J Cardiol       Date:  2017-06-26

5.  Baroreflex Control of Heart Rate in Mice Overexpressing Human SOD1: Functional Changes in Central and Vagal Efferent Components.

Authors:  Jin Chen; He Gu; Robert D Wurster; Zixi Cheng
Journal:  Neurosci Bull       Date:  2018-11-20       Impact factor: 5.203

6.  Disrupted Nitric Oxide Metabolism from Type II Diabetes and Acute Exposure to Particulate Air Pollution.

Authors:  Ashley P Pettit; Howard Kipen; Robert Laumbach; Pamela Ohman-Strickland; Kathleen Kelly-McNeill; Clarimel Cepeda; Zhi-Hua Fan; Louis Amorosa; Sara Lubitz; Stephen Schneider; Andrew Gow
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.